In May 2024, San Antonio, Texas, played host to the 18th Workshop on Recent Issues in Bioanalysis (18th WRIB). This annual gathering brings together over 1, 100 experts from pharmaceutical and biotech companies, contract research organizations (CROs), and regulatory agencies. The week-long event is
Imagine this: scientists wanted to know if mixing three different shots at once was safe for tiny tots. In a study done from June to October 2023, 600 babies aged 3 months were split into three groups. One got no shots (yikes! ), another got one shot each month, and the last group got all three shot
Imagine you're taking medicine that your body refuses to accept because it mistakenly thinks it's an invader. This is a big problem in biologic therapies, where medicines like enzymes and gene therapies can trigger unwanted immune responses, making them less effective. Scientists are tackling this i
Robert F. Kennedy Jr. , a known vaccine skeptic nominated by President Donald Trump for Health and Human Services secretary, plans to keep his financial interests in certain lawsuits brought by the law firm Wisner Baum. This firm specializes in suing pharmaceutical companies for drug injuries. Ethic
Ever wondered why some people are eager to get vaccine boosters while others aren't? A recent study across several nations found a surprising link. The study, conducted between June and August 2021, looked at people's tendency to prefer immediate smaller rewards over larger future ones, a trait know
Scientists have found an ingenious way to tackle two various health threats using just one tiny protein. This little protein, originating from the Chikungunya virus, is typically spread by mosquitoes and can trigger large outbreaks. Normally, E. coli bacteria are harmless, but sometimes they can pos
Electing Donald Trump as President has sparked discussions about potential changes to the Department of Health and Human Services (HHS). One of the most talked-about nominations is Robert F. Kennedy Jr. for Health Secretary. Kennedy is known for his vaccine skepticism and has proposed reducing the H
The United States government is putting a big chunk of money, about $590 million, into developing a bird flu vaccine. The company Moderna will use this money to keep working on a vaccine that protects against the H5 and H7 types of bird flu. This isn't the first time they're getting help; earlier th
In wealthy countries, there's a big difference in how many people get the COVID-19 vaccine. We wanted to find out why this happens at different stages of the pandemic. Some countries did way better than others in getting people vaccinated. To understand why, researchers looked at various national f
Super-resistant bacteria, or superbugs, are a real threat to people with weakened immune systems. Think cancer patients, the elderly, and those with long-term illnesses. Traditional vaccines don't work as well for these folks because their immune cells are either low in number or not functioning pro
